Northwestern Medicine
Chicago, Illinois, 60611, United States
NCT Number: NCT06531473
The primary aim is to assess the impact of laser setting frequency and wattage during holmium laser enucleation of the prostate.
Looking for future studies?
Notify Me18 year–89 year
Male
Interventional
Not applicable
Chicago, Illinois, 60611, United States
There is currently no gold-standard laser settings for HoLEP procedures. In the investigator's current high-volume practice, the following settings for enucleation are: 2J 50Hz. These settings are conventional settings, but there is no literature to prove optimal laser settings. The investigators hypothesizes that utilization of higher laser settings may be associated with a clinically significant (defined as > 10%) decrease in procedural time without any detrimental postoperative outcomes, and a utilization of lower laser settings may be associated with a clinically significant (defined as >10%) reduction in postoperative irritative voiding symptoms without any detrimental postoperative outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will be randomized to one of the laser energy groups day of surgery.
Time frame: 2 years
Comparing operative outcomes between the 40 hz, 50 hz and 60 hz laser setting groups.
Northwestern University
Other
Laser Outcomes Associated With HoLEP Procedures
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05467527
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder
Ngau Tau Kok, Kowloon, Hong Kong
View Trial DetailsNCT05086900
Behavior, Chronic Pain
Reading, Berkshire, United Kingdom
View Trial DetailsNCT04114266
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Ghent, Belgium
View Trial DetailsNCT06164600
Child, Communicable Diseases
Cairo, Abbasseiya, Egypt
View Trial Details